Terms and Conditions for Nexalin Therapy Sessions

By undergoing therapy sessions using the Nexalin device at Yasten, the patient (or their legal representative) acknowledges and agrees to the following terms and conditions:

1. Eligibility for Treatment

• The patient confirms that they do not suffer from epilepsy.
• Female patients confirm that they are not currently pregnant.
• The patient confirms that they do not have any electronic medical devices implanted or attached to their body, such as a pacemaker or cochlear implant, that could interfere with the therapy.

2. Informed Consent

• The treating physician has provided a clear explanation of the Nexalin therapy, including its purpose, method of use, potential benefits, and possible side effects or challenges.
• The patient affirms that they have had the opportunity to ask questions and that all questions have been adequately addressed.

3. Voluntary Participation

• The patient confirms that they are undergoing this treatment voluntarily, without any pressure or coercion.
• The decision to proceed with Nexalin therapy is made based on their informed understanding of the treatment.

4. Assumption of Risk

• While Nexalin therapy is considered safe and non-invasive, the patient acknowledges that individual responses may vary, and Yasten is not liable for outcomes beyond those explained by the medical team.

5. Confidentiality

• All personal and medical information shared during the treatment will be treated with strict confidentiality in accordance with Yasten’s privacy policy and local regulations.

6. Signature and Agreement

By signing below, the patient (or authorized representative) confirms that they have read, understood, and agreed to the above terms and conditions prior to beginning treatment.

Terms and Conditions for Nexalin Therapy Sessions

By undergoing therapy sessions using the Nexalin device at Yasten, the patient (or their legal representative) acknowledges and agrees to the following terms and conditions:

1. Eligibility for Treatment

• The patient confirms that they do not suffer from epilepsy.
• Female patients confirm that they are not currently pregnant.
• The patient confirms that they do not have any electronic medical devices implanted or attached to their body, such as a pacemaker or cochlear implant, that could interfere with the therapy.

2. Informed Consent

• The treating physician has provided a clear explanation of the Nexalin therapy, including its purpose, method of use, potential benefits, and possible side effects or challenges.
• The patient affirms that they have had the opportunity to ask questions and that all questions have been adequately addressed.

3. Voluntary Participation

• The patient confirms that they are undergoing this treatment voluntarily, without any pressure or coercion.
• The decision to proceed with Nexalin therapy is made based on their informed understanding of the treatment.

4. Assumption of Risk

• While Nexalin therapy is considered safe and non-invasive, the patient acknowledges that individual responses may vary, and Yasten is not liable for outcomes beyond those explained by the medical team.

5. Confidentiality

• All personal and medical information shared during the treatment will be treated with strict confidentiality in accordance with Yasten’s privacy policy and local regulations.

6. Signature and Agreement

By signing below, the patient (or authorized representative) confirms that they have read, understood, and agreed to the above terms and conditions prior to beginning treatment.